Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
Akers Biosciences reports 2023 executive compensation
By ExecPay News
Published: November 1, 2024
Akers Biosciences reported fiscal year 2023 executive compensation information on November 1, 2024.
In 2023, four executives at Akers Biosciences received on average a compensation package of $1.1M, a 337% increase compared to previous year.
Average pay of disclosed executives at Akers Biosciences
Christopher Chapman, Chief Medical Officer, received $2.9M in total, which increased by 1,002% compared to 2022. 77% of Chapman's compensation, or $2.2M, was in option awards. Chapman also received $200K in bonus, $465K in salary, as well as $1.1K in other compensation.
Adam Kaplin, Chief Scientific Officer, received a compensation package of $594K, which increased by 68% compared to previous year. 42% of the compensation package, or $250K, was in salary.
Paul Rivard, Chief Legal Officer, earned $578K in 2023, a 207% increase compared to previous year.
Ian Rhodes, Chief Financial Officer, received $162K in 2023, which is the same as previous year.
Related executives
You may also like
Source: SEC filing on November 1, 2024.